TY - JOUR
T1 - Carbonic anhydrase inhibitors
T2 - X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II
AU - Di Fiore, A
AU - De Simone, G
AU - Menchise, [No Value]
AU - Pedone, C
AU - Casini, A
AU - Scozzafava, A
AU - Supuran, CT
PY - 2005/4/1
Y1 - 2005/4/1
N2 - N-1-(4-Sulfamoylphenyl)-N-4-pentafluorophenyl-thiosemicarbazide was prepared by the reaction of 4-isothiocyanato-benzenesulfonamide with pentafluorophenyl hydrazine, and proved to be an effective inhibitor of several isozymes of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1), such as CA I, II, and IX. Against the physiologically relevant isozymes hCA II and hCA IX, the compound showed inhibition constants in the range of 15-19 nM, whereas it was less effective as a hCA I inhibitor (K-I of 78 nM). The high-resolution X-ray crystal structure of its adduct with hCA 11 showed the inhibitor to bind within the hydrophobic half of the enzyme active site, making extensive and strong van der Waals contacts with amino acid residues Gln92, Val121 Phel31, Leu198, Thr200, Pro202, in addition to the coordination of the sulfonamide nitrogen to the Zn(II) ion of the active site, and participation of the SO2NH2 group to a network of hydrogen bonds involving residues Thr199 and Glu106. These results are helpful for the design of better CA II or CA IX inhibitors based on the thioureido-benzenesulfonamide motif, with potential applications as anti-glaucoma or anti-cancer drugs. (c) 2005 Elsevier Ltd. All rights reserved.
AB - N-1-(4-Sulfamoylphenyl)-N-4-pentafluorophenyl-thiosemicarbazide was prepared by the reaction of 4-isothiocyanato-benzenesulfonamide with pentafluorophenyl hydrazine, and proved to be an effective inhibitor of several isozymes of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1), such as CA I, II, and IX. Against the physiologically relevant isozymes hCA II and hCA IX, the compound showed inhibition constants in the range of 15-19 nM, whereas it was less effective as a hCA I inhibitor (K-I of 78 nM). The high-resolution X-ray crystal structure of its adduct with hCA 11 showed the inhibitor to bind within the hydrophobic half of the enzyme active site, making extensive and strong van der Waals contacts with amino acid residues Gln92, Val121 Phel31, Leu198, Thr200, Pro202, in addition to the coordination of the sulfonamide nitrogen to the Zn(II) ion of the active site, and participation of the SO2NH2 group to a network of hydrogen bonds involving residues Thr199 and Glu106. These results are helpful for the design of better CA II or CA IX inhibitors based on the thioureido-benzenesulfonamide motif, with potential applications as anti-glaucoma or anti-cancer drugs. (c) 2005 Elsevier Ltd. All rights reserved.
KW - CRYSTALLOGRAPHIC STRUCTURE
KW - THERAPEUTIC APPLICATIONS
KW - DRUG DESIGN
KW - SULFONAMIDES
KW - ADDUCT
KW - ANTICANCER
KW - BINDING
KW - CANCER
U2 - 10.1016/j.bmcl.2005.01.086
DO - 10.1016/j.bmcl.2005.01.086
M3 - Article
VL - 15
SP - 1937
EP - 1942
JO - Bioorganic & Medicinal Chemistry Letters
JF - Bioorganic & Medicinal Chemistry Letters
SN - 0960-894X
IS - 7
ER -